100% of cancer patients cured long-term in ‘remarkable’ human trial

High hopes for the use of dostarlimab-gxly in successfully ‘reversing’ a type of colorectal cancer, with hopes it will be able to target other forms.  Depositphotos – By Bronwyn Thompson 2024 Jun 05 – In what researchers have called an “unprecedented” response, a new …